The Journal of Hip Surgery 2021; 05(02): 074-077
DOI: 10.1055/s-0041-1729869
Original Article

Short-Term Follow-Up of the PROSTALAC Implant for Primary Total Hip Arthroplasty in Patients with an Infected Native/Total Hip

Jean Chia
1   Flinders Medical Center and Flinders University, Adelaide, South Australia, Australia
,
Alfred Roy
1   Flinders Medical Center and Flinders University, Adelaide, South Australia, Australia
,
Emma Jackman
1   Flinders Medical Center and Flinders University, Adelaide, South Australia, Australia
,
Mark Inglis
1   Flinders Medical Center and Flinders University, Adelaide, South Australia, Australia
,
Christopher Wilson
1   Flinders Medical Center and Flinders University, Adelaide, South Australia, Australia
› Author Affiliations

Abstract

Infection after a total hip replacement (THR) is a significant complication for patients and is costly for health services. The two-stage Prosthesis with Antibiotic Loaded Acrylic (PROSTALAC) procedure has been the gold standard treatment for managing THR infections. The aim of this study is to evaluate using a one-stage PROSTALAC procedure as an alternative for patients who would otherwise not be able to undergo THR surgery due to a previous hip infection.

We evaluated nine cases where the PROSTALAC implant was used in the native hip. The reasons for surgery, clinical results, and complications were reviewed. An Australian Orthopaedic Association National Joint Replacement Registry data report verified that no patients were revised outside of our local center.

All patients reported symptomatic relief and satisfactory function, one patient had a peri-prosthetic fracture after experiencing a fall, and one patient underwent surgery for loosening of the joint. No cases were revised to another implant or had further infection. Minimum follow-up was 2 years.

Our results suggest that this implant is useful in patients with osteoarthritis of the hip with a history of previous infection or chronic infection of the native hip.



Publication History

Received: 03 April 2020

Accepted: 22 September 2020

Article published online:
09 June 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Postel M, Kerboul M, Evrard J, Courpied JP. eds. Total Hip Replacement. Berlin: Springer; 1987
  • 2 Natsuhara KM, Shelton TJ, Meehan JP, Lum ZC. Mortality during total hip periprosthetic joint infection. J Arthroplasty 2019; 34 (7S): S337-S342
  • 3 Scharfenberger A, Clark M, Lavoie G, O'Connor G, Masson E, Beaupre LA. Treatment of an infected total hip replacement with the PROSTALAC system. Part 1: infection resolution. Can J Surg 2007; 50 (01) 24-28
  • 4 Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD. INFORM Team. Re-infection outcomes following one-and two-stage surgical revision of infected hip prosthesis: a systematic review and meta-analysis. PLoS One 2015; 10 (09) e0139166
  • 5 Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 1998; 13 (03) 331-338
  • 6 Masri BA, Kendall RW, Duncan CP, Beauchamp CP, McGraw RW, Bora B. Two-stage exchange arthroplasty using a functional antibiotic-loaded spacer in the treatment of the infected knee replacement: the Vancouver experience. Semin Arthroplasty 1994; 5 (03) 122-136
  • 7 Lee WY, Hwang DS, Kang C, Shin BK, Zheng L. Usefulness of prosthesis made of antibiotic-loaded acrylic cement as an alternative implant in older patients with medical problems and periprosthetic hip infections: a 2-to 10-year follow-up study. J Arthroplasty 2017; 32 (01) 228-233
  • 8 AOAJNRR. Ad-Hoc Report (ID: 2089). 2016 Dec.